Ikarian Capital’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,638
| Closed | -$677K | – | 121 |
|
|
2023
Q2 | $677K | Hold |
11,638
| – | – | 0.11% | 54 |
|
|
2023
Q1 | $304K | Hold |
11,638
| – | – | 0.07% | 74 |
|
|
2022
Q4 | $347K | Sell |
11,638
-7,316
| -39% | -$218K | 0.08% | 49 |
|
|
2022
Q3 | $973K | Sell |
18,954
-37,038
| -66% | -$1.9M | 0.19% | 37 |
|
|
2022
Q2 | $1.62M | Buy |
55,992
+10,258
| +22% | +$297K | 0.3% | 35 |
|
|
2022
Q1 | $2.4M | Sell |
45,734
-29,749
| -39% | -$1.56M | 0.32% | 34 |
|
|
2021
Q4 | $5.19M | Sell |
75,483
-9,181
| -11% | -$631K | 0.77% | 19 |
|
|
2021
Q3 | $13.4M | Sell |
84,664
-5,979
| -7% | -$949K | 0.95% | 5 |
|
|
2021
Q2 | $17.7M | Buy |
90,643
+3,477
| +4% | +$678K | 1.43% | 3 |
|
|
2021
Q1 | $22.5M | Buy |
87,166
+59,619
| +216% | +$15.4M | 0.76% | 2 |
|
|
2020
Q4 | $5.31M | Buy |
27,547
+3,391
| +14% | +$654K | 0.23% | 34 |
|
|
2020
Q3 | $4.91M | Buy |
24,156
+23,989
| +14,365% | +$4.87M | 0.36% | 26 |
|
|
2020
Q2 | $47K | Buy |
+167
| New | +$47K | ﹤0.01% | 84 |
|
|
2020
Q1 | – | Sell |
-333
| Closed | -$107K | – | 116 |
|
|
2019
Q4 | $107K | Buy |
+333
| New | +$107K | 0.02% | 47 |
|